253 related articles for article (PubMed ID: 28411166)
1. Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis.
Zuily S; Domingues V; Suty-Selton C; Eschwège V; Bertoletti L; Chaouat A; Chabot F; Regnault V; Horn EM; Erkan D; Wahl D
Autoimmun Rev; 2017 Jun; 16(6):576-586. PubMed ID: 28411166
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Chock YP; Moulinet T; Dufrost V; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2019 Nov; 18(11):102395. PubMed ID: 31520800
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Bernardoff I; Picq A; Loiseau P; Foret T; Dufrost V; Moulinet T; Unlu O; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2022 Jan; 21(1):102913. PubMed ID: 34371159
[TBL] [Abstract][Full Text] [Related]
4. Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Loiseau P; Foret T; DeFilippis EM; Risse J; Etienne AD; Dufrost V; Moulinet T; Erkan D; Devilliers H; Wahl D; Zuily S
Lupus; 2022 Nov; 31(13):1595-1605. PubMed ID: 36112747
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Domingues V; Chock EY; Dufrost V; Risse J; Seshan SV; Barbhaiya M; Sartelet H; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2022 Oct; 21(10):103158. PubMed ID: 35907609
[TBL] [Abstract][Full Text] [Related]
6. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies.
Zuily S; Regnault V; Selton-Suty C; Eschwège V; Bruntz JF; Bode-Dotto E; De Maistre E; Dotto P; Perret-Guillaume C; Lecompte T; Wahl D
Circulation; 2011 Jul; 124(2):215-24. PubMed ID: 21690492
[TBL] [Abstract][Full Text] [Related]
7. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.
Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S
Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303
[TBL] [Abstract][Full Text] [Related]
8. Higher Incidence of Pulmonary Hypertension in Antiphospholipid Antibody Positive Lupus.
Ware D; Sharma V; Kalekar L; Kamble A; Mahajan A; Gokhale Y
J Assoc Physicians India; 2015 Apr; 63(4):17-20. PubMed ID: 26591164
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
11. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
Wahl DG; Guillemin F; de Maistre E; Perret C; Lecompte T; Thibaut G
Lupus; 1997; 6(5):467-73. PubMed ID: 9229367
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.
Cefle A; Inanc M; Sayarlioglu M; Kamali S; Gul A; Ocal L; Aral O; Konice M
Rheumatol Int; 2011 Feb; 31(2):183-9. PubMed ID: 20012052
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus.
Gustafsson JT; Gunnarsson I; Källberg H; Pettersson S; Zickert A; Vikerfors A; Möller S; Rönnelid J; Elvin K; Svenungsson E
Ann Rheum Dis; 2015 Aug; 74(8):1537-43. PubMed ID: 24692586
[TBL] [Abstract][Full Text] [Related]
14. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
15. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
Monti M; Borgognoni F; Pastacci L; Vincentelli GM
G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504
[TBL] [Abstract][Full Text] [Related]
16. Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis.
Abdel-Wahab N; Talathi S; Lopez-Olivo MA; Suarez-Almazor ME
Lupus; 2018 Apr; 27(4):572-583. PubMed ID: 28945149
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
18. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
20. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M
Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]